Eplerenone

Product NDC: 59762-1107
11-digit product format: 597621107
Labeler code: 59762
Product ID: 59762-1107_b4bf45ee-6524-4a9d-9d7d-91886e32ee72
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: eplerenone
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: NDA021437
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2024-12-13
Substance: EPLERENONE
Active strength: 25 mg/1
Pharmacologic classes: Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021437-001	INSPRA	EPLERENONE	25MG	TABLET / ORAL	AB	RLD	2002-09-27
N021437-002	INSPRA	EPLERENONE	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27
N021437-003	INSPRA	EPLERENONE	100MG	TABLET / ORAL			2002-09-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N021437-001	AB
N021437-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021437-002	INSPRA	50MG	TABLET / ORAL	AB	RLD, RS	2002-09-27	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021437-003	INSPRA	100MG	TABLET / ORAL			2002-09-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021437-001	INSPRA	25MG	TABLET / ORAL	AB	RLD	2002-09-27	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N021437-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N021437-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N021437-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021437-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021437-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021437-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021437-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021437-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021437-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021437-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021437-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021437-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021437-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021437-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021437-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021437-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021437-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021437-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021437-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021437-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021437-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021437-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021437-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021437-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021437-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021437-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021437-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021437-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021437-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021437-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021437-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021437-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021437-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021437-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021437-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021437-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021437-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021437-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021437-002	AB	1	`bb7c543d1eb4…`

Observed Orange Book patent history#

Patent history page 1 of 7 · 246 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N021437-001	6410524	2019-11-05	U-467		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6747020	2019-11-05	U-587		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6410054	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6410054	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6495165	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6495165	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6534093	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6534093	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6558707	2019-12-08	U-537	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	7157101	2019-12-08	U-664	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6410524*PED	2020-05-05		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6747020*PED	2020-05-05		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6410054*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6495165*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6534093*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	6558707*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-001	7157101*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6410524	2019-11-05	U-467		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6747020	2019-11-05	U-587		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6410054	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6410054	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6495165	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6495165	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6534093	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6534093	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6558707	2019-12-08	U-537	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	7157101	2019-12-08	U-664	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6410524*PED	2020-05-05		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6747020*PED	2020-05-05		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6410054*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6495165*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6534093*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	6558707*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-002	7157101*PED	2020-06-08		Pediatric extension	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6410524	2019-11-05	U-467		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6747020	2019-11-05	U-587		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6410054	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6410054	2019-12-08	U-537		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6495165	2019-12-08	U-3		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021437-003	6495165	2019-12-08	U-537		`74a2ff9319b5…`

Additional Listing Data#

Finished product: Yes
Brand name base: Eplerenone
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
EPLERENONE	25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6995V82D0B	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
351256	Internal RxNorm lookup
351257	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
4286699b-2320-4d3d-831c-32085f36fb67	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6c046e2c-42d6-3179-f149-f207119f6ad5	Product name	6	20240530

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59762-1107-2	Eplerenone	30 in 1 BOTTLE	TABLET, FILM COATED	30		46
59762-1107-3	Eplerenone	90 in 1 BOTTLE	TABLET, FILM COATED	90		46

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-1107-2	EA - Each	59762-1107	1100f87b-ea88-48bf-b14f-190895433a6a	1	2025-01-14
59762-1107-3	EA - Each	59762-1107	047a8b0c-a47d-40d8-95a7-e09a7dda4f67	1	2025-11-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59762-1107	EPLERENONE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.]	3	Current NDC, 2 package rows	20250503_4286699b-2320-4d3d-831c-32085f36fb67.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Inspra	EPLERENONE	Viatris Specialty LLC	1a52bedc-8e2c-4116-a296-a87770676b4a	2025-06-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021437 application number: NDA021437
Eplerenone	EPLERENONE	Mylan Pharmaceuticals Inc.	4286699b-2320-4d3d-831c-32085f36fb67	2025-06-23	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021437 application number: NDA021437 ndc (product): 59762-1107
Eplerenone	EPLERENONE	Mylan Pharmaceuticals Inc.	6d988699-95c2-46b9-8266-23fe7016f33b	2020-08-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021437 application number: NDA021437

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6995V82D0B	EPLERENONE	107724-20-9	EPLERENONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
351256	eplerenone 25 MG Oral Tablet	PSN	4286699b-2320-4d3d-831c-32085f36fb67	46
351257	eplerenone 50 MG Oral Tablet	PSN	4286699b-2320-4d3d-831c-32085f36fb67	46
351256	eplerenone 25 MG Oral Tablet	SCD	4286699b-2320-4d3d-831c-32085f36fb67	46
351257	eplerenone 50 MG Oral Tablet	SCD	4286699b-2320-4d3d-831c-32085f36fb67	46

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
59762-1107-2	59762110702	30 TABLET, FILM COATED in 1 BOTTLE (59762-1107-2)	2024-12-13	No	No	Current
59762-1107-3	59762110703	90 TABLET, FILM COATED in 1 BOTTLE (59762-1107-3)	2025-10-24	No	No	Current